Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -32.77% is 93% above its 5-year average of -478.71%, near the high end of its 5-year range (-8517.98%–54.25%).
60.76% above its 12-month average of -83.51%.
Reported quarterly EBITDA margin; no daily interpolation. Q3 FY2026 (2026-06-30): -120.49%.
EBITDA MARGIN
-32.77%
EBITDA MARGIN AVG TTM
-83.51%
EBITDA MARGIN AVG 3Y
-199.58%
EBITDA MARGIN AVG 5Y
-478.71%
EBITDA MARGIN AVG 10Y
-2110.28%
EBITDA MARGIN AVG 15Y
-2673.22%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+60.76%
CURRENT VS 3Y AVG
+83.58%
CURRENT VS 5Y AVG
+93.15%
CURRENT VS 10Y AVG
+98.45%
CURRENT VS 15Y AVG
+98.77%
CURRENT VS 20Y AVG
N/A
NeuroOne Medical Technologies Corporation
Market Cap
$9.75M
EBITDA Margin
-32.77%
TTM Avg
-83.51%
3Y Avg
-199.58%
5Y Avg
-478.71%
Market Cap
$9.68M
EBITDA Margin
-7418.23%
TTM Avg
-25513.08%
3Y Avg
-14528.12%
5Y Avg
-11171.17%
Market Cap
$10.10M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.15M
EBITDA Margin
-685.63%
TTM Avg
-612.49%
3Y Avg
-514.11%
5Y Avg
-584.57%
Market Cap
$9.31M
EBITDA Margin
-985.17%
TTM Avg
-7100.73%
3Y Avg
-7100.73%
5Y Avg
-7100.73%
Market Cap
$9.29M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.26M
EBITDA Margin
-75.15%
TTM Avg
-68.19%
3Y Avg
-159.10%
5Y Avg
-185.14%
Market Cap
$10.37M
EBITDA Margin
-2995.72%
TTM Avg
-2995.72%
3Y Avg
-2995.72%
5Y Avg
-2995.72%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroOne Medical Technologies Corporation (NMTC) | $9.75M | -32.77% | -83.51% | -199.58% | -478.71% |
| MetaVia Inc. (MTVA)vs › | $9.75M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.68M | -7418.23% | -25513.08% | -14528.12% | -11171.17% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | N/A | N/A | N/A | N/A |
| Valion Bio, Inc. (VBIO)vs › | $10.15M | -685.63% | -612.49% | -514.11% | -584.57% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.31M | -985.17% | -7100.73% | -7100.73% | -7100.73% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.29M | N/A | N/A | N/A | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.26M | -75.15% | -68.19% | -159.10% | -185.14% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.37M | -2995.72% | -2995.72% | -2995.72% | -2995.72% |
| Polyrizon Ltd. (PLRZ)vs › | $10.37M | N/A | N/A | N/A | N/A |
Gross Margin
67.3%
EBITDA Margin
-32.8%
Operating Margin
-34.9%
Net Margin
-71.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -120.49% |
| 2026-03-31 | -85.35% |
| 2025-12-31 | -56.76% |
| 2025-09-30 | -47.68% |
| 2025-06-30 | -107.31% |
| 2025-03-31 | -188.55% |
| 2024-12-31 | 54.25% |
| 2024-09-30 | -1010.93% |
| 2024-06-30 | -330.69% |
| 2024-03-31 | -205.13% |
| 2023-12-31 | -340.80% |
| 2023-09-30 | -418.22% |
| 2023-06-30 | -548.22% |
| 2023-03-31 | -740.49% |
| 2022-12-31 | -1525.99% |
| 2022-09-30 | -1986.94% |
| 2022-06-30 | -8517.98% |
| 2022-03-31 | -8285.81% |
| 2021-12-31 | -8249.86% |
| 2021-09-30 | -5348.55% |
| 2021-06-30 | -7496.92% |
| 2021-03-31 | -12988.06% |
| 2020-12-31 | -2972.64% |
| 2020-09-30 | -5.38% |
| 2016-03-31 | -2397.06% |
| 2015-12-31 | -5184.70% |
| 2015-09-30 | -5393.75% |
| 2015-06-30 | -6222.33% |
| 2015-03-31 | -8472.57% |
| 2014-12-31 | -5950.00% |
| 2014-09-30 | -4402.88% |
| 2014-06-30 | -5286.80% |
| 2014-03-31 | -2162.42% |
| 2013-12-31 | -1845.00% |
| 2013-09-30 | -1876.98% |
| 2013-06-30 | -3280.49% |
| 2013-03-31 | -735.22% |
| 2012-12-31 | -379.72% |
| 2012-09-30 | -20569.57% |
| 2012-06-30 | -584.65% |
| 2012-03-31 | -3754.42% |
| 2011-12-31 | -5204.71% |
| 2011-09-30 | -508.13% |
| 2011-06-30 | -97.04% |
| 2011-03-31 | -216.93% |
| 2010-09-30 | -1904.03% |
| 2010-06-30 | -698.24% |
